1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may link to a different grant program than the one shown here.
We recommend visiting the funder’s website directly to confirm this opportunity is available.
Search verified grants from National Institutes of Health (NIH) / National Institute of Neurological Disorders and Stroke (NINDS) →BRAIN Initiative: Research Opportunities Using Invasive Neural Recording and Stimulating Technologies in the Human Brain (R01 Clinical Trial Not Allowed) is sponsored by National Institutes of Health (NIH) / National Institute of Neurological Disorders and Stroke (NINDS). Supports research to record or stimulate neural activity using invasive surgical procedures in humans.
Highly relevant for university research teams developing or testing intraoperative nerve monitoring devices and neural interfaces within clinical settings.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Higher Education Institutions (Public/Private Universities), non-profits, for-profits, and foreign/domestic institutions. Confirm the full requirements in the official notice before applying.
BRAIN Initiative: Research Opportunities Using Invasive Neural Recording and Stimulating Technologies in the Human Brain (R01 Clinical Trial Not Allowed) is funded by National Institutes of Health (NIH) / National Institute of Neurological Disorders and Stroke (NINDS). Verify program details on the funder's official page before applying.
Past winners and funding trends for this program
PAR-27-062 creates a three-year, $80,000-salary postdoctoral career award across NCI, NIAID, NIBIB, NIDCR and NINDS — and it carries a hard eligibility window that closes two years after you start your postdoc. Full analysis of the Academic Career Excellence Award, what it replaces, and why the timing rule is the whole competition.
Read articleThe HEAL Initiative's Studies to Enable Analgesic Discovery award (RFA-NS-25-023) puts federal money exactly where private capital won't go — the assay-building, screening, and hit-characterization stage of non-opioid pain therapeutics. It's a phased R61/R33, up to $350,000 in direct costs per year, with the next application deadline September 17, 2026. Here is how the two-phase structure works, who's eligible, and how to build a proposal that survives the R61-to-R33 milestone gate.
Read articleNIH's RFI on administrative burden (NOT-OD-26-118) takes comments through December 8, 2026. It asks seven questions, lists eight reforms already made, and warns that responses may be posted unredacted. Here is what NIH is really asking for, what it can and cannot change alone, and how researchers and research offices should respond.
Read article